ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PRQR ProQR Therapeutics NV

2.45
0.18 (7.93%)
15 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ProQR Therapeutics NV NASDAQ:PRQR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.18 7.93% 2.45 2.30 2.53 2.44 2.26 2.26 130,688 01:00:00

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

12/02/2025 2:46pm

Edgar (US Regulatory)


EXHIBIT 99.1

JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

DATED: 02/12/2025

 

ADAGE CAPITAL MANAGEMENT, L.P.  
By: Adage Capital Partners LLC,  
its General Partner  
   
/s/ Robert Atchinson  
Name:  Robert Atchinson  
Title: Managing Member  
   
/s/ Robert Atchinson  
ROBERT ATCHINSON, individually  
   
/s/ Phillip Gross  
PHILLIP GROSS, individually  

 

 

 

 


1 Year ProQR Therapeutics NV Chart

1 Year ProQR Therapeutics NV Chart

1 Month ProQR Therapeutics NV Chart

1 Month ProQR Therapeutics NV Chart